Date | Insider | Price | Amount |
---|---|---|---|
2-4-2014 Insider Buy |
Todd Foley Director |
$8.00 CAGR » |
$892,864.00 111,608 shares |
2-4-2014 Insider Buy |
Enterprise Partners Management LLC >10% Owner |
$8.00 CAGR » |
$1,064,664.00 133,083 shares |
2-4-2014 Insider Buy |
Joshua Funder Director |
$8.00 CAGR » |
$1,818,088.00 227,261 shares |
2-4-2014 Insider Buy |
Johan Kordel Director |
$8.00 CAGR » |
$1,461,448.00 182,681 shares |
2-4-2014 Insider Buy |
Invest A/S Lundbeckfond >10% Owner |
$8.00 CAGR » |
$1,461,448.00 182,681 shares |
2-4-2014 Insider Buy |
Michael Narachi Director |
$8.00 CAGR » |
$500,000.00 62,500 shares |
2-4-2014 Insider Buy |
Bioventures Ltd Novartis >10% Owner |
$8.00 CAGR » |
$1,299,088.00 162,386 shares |
2-4-2014 Insider Buy |
Inc Pfizer >10% Owner |
$8.00 CAGR » |
$1,818,088.00 227,261 shares |
2-4-2014 Insider Buy |
Fredrik Wiklund VP Corp Dvlpmnt & Invs Rltns |
$8.00 CAGR » |
$160,000.00 20,000 shares |
Also See: Institutional Holders of CLDN
Also See: SEC filings
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 02/05/2014 | |
End date: | 03/22/2016 | |
Start price/share: | $7.70 | |
End price/share: | $1.15 | |
Dividends collected/share: | $0.00 | |
Total return: | -85.06% | |
Average Annual Total Return: | -59.16% | |
Starting investment: | $10,000.00 | |
Ending investment: | $1,493.56 | |
Years: | 2.12 |
CLDN Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent CLDN insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding CLDN
Free CLDN Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |